Ignite Creation Date:
2024-05-05 @ 4:59 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00363012
Status:
COMPLETED
Last Update Posted:
2017-04-05
First Post:
2006-08-10
Brief Title:
Immune Response in Patients Who Have Undergone Vaccine Therapy for Stage III or Stage IV Breast Cancer That Overexpresses HER2
Sponsor:
Organization:
University of Washington